Cencora (COR) Competitors

McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, community ranking, media sentiment and analyst recommendations.

Do analysts recommend MCK or COR?

McKesson currently has a consensus target price of $650.14, indicating a potential upside of 12.14%. Cencora has a consensus target price of $275.60, indicating a potential upside of 21.04%. Given Cencora's higher possible upside, analysts clearly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.94
Cencora	0 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.82

Does the media favor MCK or COR?

In the previous week, McKesson had 2 more articles in the media than Cencora. MarketBeat recorded 12 mentions for McKesson and 10 mentions for Cencora. McKesson's average media sentiment score of 0.90 beat Cencora's score of 0.67 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cencora	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community favor MCK or COR?

McKesson received 224 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.23% of users gave McKesson an outperform vote while only 65.38% of users gave Cencora an outperform vote.

Company	Underperform	Outperform
McKesson	Outperform Votes 968 74.23%	Underperform Votes 336 25.77%
Cencora	Outperform Votes 744 65.38%	Underperform Votes 394 34.62%

Is MCK or COR more profitable?

McKesson has a net margin of 0.77% compared to Cencora's net margin of 0.51%. Cencora's return on equity of 266.62% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	0.77%	-207.50%	5.45%
Cencora	0.51%	266.62%	4.20%

Do insiders & institutionals hold more shares of MCK or COR?

85.1% of McKesson shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 15.8% of Cencora shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has preferable valuation and earnings, MCK or COR?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$330.19B	0.22	$3.00B	$19.31	30.02
Cencora	$638.56M	68.92	$1.51B	$7.51	30.32

Which has more risk and volatility, MCK or COR?

McKesson has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500.

Is MCK or COR a better dividend stock?

McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.5%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 1.0%. McKesson pays out 14.7% of its earnings in the form of a dividend. Cencora pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has raised its dividend for 17 consecutive years and Cencora has raised its dividend for 15 consecutive years.

Summary

McKesson beats Cencora on 15 of the 22 factors compared between the two stocks.